COMMUNIQUÉS West-GlobeNewswire

Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
31/01/2018
SAN DIEGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd., or Arcturus (NASDAQ: ARCT ), an RNA medicines company, today announced that it will hold an extraordinary general meeting of shareholders on [...]
Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
31/01/2018
DUBLIN and SHANGHAI - January 30, 2018 - Medtronic plc (NYSE: MDT ) today announced that Alex Gu, previously Vice President, Regional Growth Initiatives, Greater China, and leader of Medtronic's Minimally Invasive [...]
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, California
31/01/2018
LA JOLLA, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
National Research Corporation to Broadcast its 2017 Fourth Quarter and Year-End Conference Call Live on the Internet
30/01/2018
Lincoln, Nebraska, Jan. 30, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA ) (NASDAQ: NRCIB ) today announced that it will provide an online web simulcast of its 2017 fourth quarter and year-end [...]
Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals
30/01/2018
VANCOUVER, British Columbia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States
30/01/2018
HOUSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Avinger Announces Reverse Stock Split
30/01/2018
REDWOOD CITY, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will effect a 1- [...]
Vistin Pharma ASA : Vistin Pharma to postpone the expansion of the metformin production capacity
30/01/2018
Oslo, Norway, 30 January 2018 Norwegian pharmaceutical company Vistin Pharma ASA announced today that it has decided to postpone the construction of the new NOK 120 million production line at the Company's dedicated [...]
Vical Announces Restructuring to Focus Resources on HSV-2 and Antifungal Clinical Programs
30/01/2018
SAN DIEGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced a restructuring to conserve capital and to focus its efforts on VL-2397, its antifungal drug product candidate which is [...]
Solid Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option
30/01/2018
CAMBRIDGE, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB ) (the “Company” or “SLDB”), announced today the closing of its initial public offering of 8,984,375 shares of its common stock, [...]
Advanced Biomedical Technologies Inc. Granted New Patent Strengthening its Core Technology
30/01/2018
SHENZHEN, CHINA and NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Advanced Biomedical Technologies Inc. (OTCQB:ABMT), a developer and manufacturer of orthopaedic internal fixation devices, today announced the State [...]
AveXis to Initiate Screening for Remaining Patients in Pivotal Trial of AVXS-101 for SMA Type 1 Following Review of Preliminary Data from First Three Patients
30/01/2018
CHICAGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]
resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
30/01/2018
BOSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging- [...]
Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility
30/01/2018
SANTA BARBARA, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ) (“Sientra” or the “Company”), a medical aesthetics company, today provided an update on its pre-market approval (PMA) supplement for [...]
FOR IMMEDIATE RELEASE: The importance of mental health literacy among all of the awareness
30/01/2018
HALIFAX, Nova Scotia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Today our media feeds will be filled with support for mental illness and it will feel like awareness is high, but awareness alone is not enough. “While mental [...]
Rheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and Competition
30/01/2018
Washington, DC, Jan. 30, 2018 (GLOBE NEWSWIRE) -- In its response to the U.S. Department of Health and Human Services’ latest Request for Information on Promoting Health Care Choice and Competition Across the United [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2017
30/01/2018
Communiqué de presse Villepinte, le 30 janvier 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
Invitation to Idorsia's full year results 2017 webcast and conference call
30/01/2018
Idorsia will publish its full year financial results 2017 on Tuesday 6 February 2018 at 07:00 CET. An investor conference call and webcast will be held to discuss the results on the same day at 14:00 CET / 13:00 GMT / [...]
CORRECTING and REPLACING -- Innovate Biopharmaceuticals Announces Successful Merger Completion
30/01/2018
RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT ) please note that the stock symbol for Monster Digital, Inc [...]

Pages